I2I
DGX icon

Insight 2811 Inc’s Quest Diagnostics DGX Stock Holding History

Insight 2811 Inc’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-106
Closed -$21K – 133
2014
Q3 		$21K Buy
+106
New +$6.53K 0.01% 128

Other funds holding DGX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BA
BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
DSA
Davis Selected Advisers Tucson, Arizona $21.8B AUM 23.45% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

Insight 2811 Inc's DGX Position: Q1 2015 in Review

Insight 2811 Inc sold out of Quest Diagnostics (DGX) in Q1 2015, closing a stake of 10,000 shares — an estimated $671K sold.

Insight 2811 Inc first reported a position in DGX in Q1 2014 and held it in 4 quarters. The position peaked at $904K in Q2 2014. 553 funds tracked by Wall St. Rank hold DGX as of Q1 2015.

  • Insight 2811 Inc reported no remaining Quest Diagnostics position as of Q1 2015 after selling out during the quarter.
  • Insight 2811 Inc sold 10,000 Quest Diagnostics shares in Q1 2015, an estimated $671K.
  • Insight 2811 Inc first reported a position in Quest Diagnostics in Q1 2014 and held it in 4 quarters.
  • Insight 2811 Inc's Quest Diagnostics position peaked at $904K in Q2 2014.
  • 553 funds tracked by Wall St. Rank held Quest Diagnostics as of Q1 2015.

Based on Insight 2811 Inc's 13F filing for Q1 2015, filed 24 Apr 2015.